Bioveža - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 18,373 | 10,939 | 4,222 | 18,837 | 13,902 | 16,550 | 28,287 | 20,746 |
| Profit before tax | -4,816 | -3,949 | -4,389 | 5,536 | 2,611 | 2,926 | 8,527 | 1,142 |
| Net profit | -4,816 | -3,949 | -4,389 | 5,536 | 2,611 | 2,926 | 8,298 | 1,073 |
| Equity | -3,213 | -7,162 | -11,551 | -6,015 | -3,404 | -478 | 8,049 | 8,893 |
| Liabilities | 6,603 | 9,269 | 13,619 | 11,228 | 11,493 | 11,492 | 11,910 | 12,126 |
| Non-current assets | 1,616 | 748 | 290 | 604 | 289 | 97 | 2,042 | 1,634 |
| Current assets | 1,774 | 1,359 | 1,778 | 4,609 | 7,800 | 10,917 | 17,917 | 19,385 |
| Total assets | 3,390 | 2,107 | 2,068 | 5,213 | 8,089 | 11,014 | 19,959 | 21,019 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,096 | 1,520 | 2,190 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +140.0% | -40.5% | -61.4% | +346.2% | -26.2% | +19.0% | +70.9% | -26.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -142.1% | -187.4% | -212.2% | 106.2% | 32.3% | 26.6% | 41.6% | 5.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | 103.1% | 12.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -26.2% | -36.1% | -104.0% | 29.4% | 18.8% | 17.7% | 29.3% | 5.2% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -26.2% | -36.1% | -104.0% | 29.4% | 18.8% | 17.7% | 30.1% | 5.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | 1.5 | 1.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 8,166 | 4,102 | 2,111 | 6,648 | 5,958 | 7,944 | 14,144 | 10,373 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Bioveža - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-06 | 1.04 |
| 2026-08-26 | 2026-09-02 | 1.04 |
| 2026-08-23 | 2026-08-23 | 1.04 |
| 2026-08-19 | 2026-08-19 | 1.04 |
| 2026-07-19 | 2026-08-05 | 1.04 |
| 2026-07-16 | 2026-07-17 | 1.04 |
| 2026-06-16 | 2026-07-06 | 1.04 |
Bioveža - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Bioveža, UAB (code 303356652) is a Private Limited Liability Company operating in materials recovery. In 2025, the company generated revenue of €20.7K and net profit of €1.1K, with a profit margin of 5.2%. Revenue declined by 26.7% year on year from €28.3K in 2024, but remained 25.4% above the 2023 level of €16.6K, showing a mixed two-year trajectory. Profitability also weakened from €8.3K in 2024 to €1.1K in 2025 after €2.9K in 2023. At the end of 2025, total assets reached €21.0K, supported by equity of €8.9K and liabilities of €12.1K. The equity ratio stood at 42.3% and debt-to-equity at 1.36. Return on equity was 12.1%, return on assets 5.1%, and asset turnover 0.99x. Revenue per employee was €10.4K and profit per employee €536, indicating modest operating scale in 2025.